• Explore /
  • Poster
  • / Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic castration-sensitive prostate cancer: A pooled analysis of the STOMP and ORIOLE trials.

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic castration-sensitive prostate cancer: A pooled analysis of the STOMP and ORIOLE trials.

Abstract Poster

Authors

null

Mathew Pierre Deek

Rutgers Cancer Institute, Baltimore, NJ

Mathew Pierre Deek , Kim Van der Eecken , Phillip Sutera , Rebecca A Deek , Valerie Fonteyne , Adrianna Mendes , Nicolaas Lumen , Ryan Phillips , Louke Delrue , Sofie Verbeke , Kathia De Man , Daniel Y. Song , Channing Judith Paller , Steven Joniau , Gert De Meerleer , Tamara L. Lotan , Alejandro Berlin , Shankar Siva , Piet Ost , Phuoc T. Tran

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

NCT02680587

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5025)

DOI

10.1200/JCO.2022.40.16_suppl.5025

Abstract #

5025

Poster Bd #

209

Abstract Disclosures

Similar Posters

First Author: Corbin J. Eule

First Author: Charles J. Ryan

First Author: Soha Bazyar

First Author: Justin Shaya